Clinical Trials
59
Active:5
Completed:19
Trial Phases
5 Phases
Phase 1:6
Phase 2:12
Phase 3:20
+2 more phases
Drug Approvals
24
NMPA:17
FDA:7
Drug Approvals
Sunitinib Malate Capsules
- Product Name
- 苹果酸舒尼替尼胶囊
- Approval Number
- 国药准字HJ20240157
- Approval Date
- Dec 1, 2024
NMPA
Sacubitril Valsartan Sodium Tablets
- Product Name
- 沙库巴曲缬沙坦钠片
- Approval Number
- 国药准字HJ20240113
- Approval Date
- Oct 22, 2024
NMPA
Sacubitril Valsartan Sodium Tablets
- Product Name
- 沙库巴曲缬沙坦钠片
- Approval Number
- 国药准字HJ20240112
- Approval Date
- Oct 22, 2024
NMPA
Quetiapine Fumarate Tablets
- Product Name
- 富马酸喹硫平片
- Approval Number
- 国药准字HJ20240031
- Approval Date
- Jun 4, 2024
NMPA
Quetiapine Fumarate Tablets
- Product Name
- 富马酸喹硫平片
- Approval Number
- 国药准字HJ20240032
- Approval Date
- Jun 4, 2024
NMPA
Quetiapine Fumarate Tablets
- Product Name
- 富马酸喹硫平片
- Approval Number
- 国药准字HJ20240033
- Approval Date
- Jun 4, 2024
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (52 trials with phase data)• Click on a phase to view related trials
Phase 3
20 (38.5%)Phase 2
12 (23.1%)Not Applicable
11 (21.2%)Phase 1
6 (11.5%)Phase 4
3 (5.8%)No trials found
News
No news found